Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS
出版年份 2014 全文链接
标题
Identification of prohibitin 1 as a potential prognostic biomarker in human pancreatic carcinoma using modified aqueous two-phase partition system combined with 2D-MALDI-TOF-TOF-MS/MS
作者
关键词
Pancreatic carcinoma, Prohibitin 1, Tumor biomarker, Membrane proteome, Apoptosis
出版物
TUMOR BIOLOGY
Volume 36, Issue 2, Pages 1221-1231
出版商
Springer Nature
发表日期
2014-10-25
DOI
10.1007/s13277-014-2742-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prohibitin Induces Apoptosis in BGC823 Gastric Cancer Cells Through the Mitochondrial Pathway
- (2013) Long Zhang et al. Asian Pacific Journal of Cancer Prevention
- Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential
- (2013) Frédéric Thuaud et al. CHEMISTRY & BIOLOGY
- Signaling pathways of prohibitin and its role in diseases
- (2013) Tian-Biao Zhou et al. JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
- Gonadotropin-Releasing Hormone-Regulated Prohibitin Mediates Apoptosis of the Gonadotrope Cells
- (2013) Dana Savulescu et al. MOLECULAR ENDOCRINOLOGY
- Molecularly Targeted Therapies in Metastatic Pancreatic Cancer
- (2013) Flora Zagouri et al. PANCREAS
- The role and therapeutic potential of prohibitin in disease
- (2011) Arianne L. Theiss et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Marine Natural Product Aurilide Activates the OPA1-Mediated Apoptosis by Binding to Prohibitin
- (2011) Shin-ichi Sato et al. CHEMISTRY & BIOLOGY
- Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication
- (2010) Wasia Rizwani et al. CELL CYCLE
- Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice
- (2010) Kwang Suk Ko et al. HEPATOLOGY
- Increased Expression of Prohibitin and its Relationship with Poor Prognosis in Esophageal Squamous Cell Carcinoma
- (2010) Hong-Zheng Ren et al. PATHOLOGY & ONCOLOGY RESEARCH
- Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
- (2010) N. Patel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-wide analysis of integral membrane proteins from eubacterial, archaean, and eukaryotic organisms
- (2010) Erik Wallin et al. PROTEIN SCIENCE
- Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
- (2009) D Alwyn Dart et al. ENDOCRINE-RELATED CANCER
- Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry
- (2009) H Lallet-Daher et al. ONCOGENE
- Proteomics of Pancreatic Cancer
- (2009) Ilona Gräntzdörffer et al. PANCREAS
- Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer
- (2008) Ramesh Ummanni et al. CANCER LETTERS
- MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin
- (2008) Tao Liu et al. CANCER LETTERS
- Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis
- (2008) Rosalind C. Gregory-Bass et al. INTERNATIONAL JOURNAL OF CANCER
- Prohibitin: a potential biomarker for tissue-based detection of gastric cancer
- (2008) Xiangdong Kang et al. JOURNAL OF GASTROENTEROLOGY
- Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy
- (2008) Yandong Nan et al. MEDICAL ONCOLOGY
- Aqueous Polymer Two-Phase Systems for the Proteomic Analysis of Plasma Membranes from Minute Brain Samples
- (2007) Jens Schindler et al. JOURNAL OF PROTEOME RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started